|
1'-[(3-chlorophenyl)methyl]-3-(3,4-difluorophenyl)-5'-nitro-1,1-dioxo-spiro[1,3-thiazolidine-2,3'-indoline]-2',4-dione |
|
Mycobacterium |
Exoenzyme |
Preclinical (in vitro) |
Vintonyak VV, et al. 2010. Angew Chem Int Ed Engl |
|
1'-[(4-bromophenyl)methyl]-3-(3,4-difluorophenyl)-5'-nitro-1,1-dioxo-spiro[1,3-thiazolidine-2,3'-indoline]-2',4-dione |
Depiction based on curated SMILES
N
+
N
O
_
O
F
F
N
S
O
O
O
O
Br
|
Mycobacterium |
Exoenzyme |
Preclinical (in vitro) |
Vintonyak VV, et al. 2010. Angew Chem Int Ed Engl |
|
1'-[(4-chlorophenyl)methyl]-3-(3,4-difluorophenyl)-5'-nitro-1,1-dioxo-spiro[1,3-thiazolidine-2,3'-indoline]-2',4-dione |
Depiction based on curated SMILES
N
+
N
O
_
O
F
F
N
S
O
O
O
O
Cl
|
Mycobacterium |
Exoenzyme |
Preclinical (in vitro) |
Vintonyak VV, et al. 2010. Angew Chem Int Ed Engl |
|
1-(3,4-dichlorophenyl)-2-[2-imino-3-(2-piperidin-1-ium-1-ylethyl)benzimidazol-1-yl]ethanone |
Depiction based on curated SMILES
Cl
Cl
O
HN
N
N
H
+
N
|
Mycobacterium |
Motility |
Preclinical (in vitro) |
Ouertatani-Sakouhi H, et al. 2017. PLoS One |
|
1-(4-chlorobenzoyl)-3-decyl-2-methylindole-5-sulfonic acid |
Depiction based on curated SMILES
S
O
O
OH
O
Cl
H
3
C
H
3
C
N
|
Mycobacterium |
Exoenzyme |
Preclinical (in vitro) |
Nören-Müller A, et al. 2006. Proc Natl Acad Sci U S A |
|
1-(4-chlorobenzoyl)-3-[(4-hydroxyphenyl)methyl]-2-methylindole-5-sulfonic acid |
Depiction based on curated SMILES
HO
HO
O
O
S
H
3
C
Cl
O
N
|
Mycobacterium |
Exoenzyme |
Preclinical (in vitro) |
Nören-Müller A, et al. 2006. Proc Natl Acad Sci U S A |
|
1-(5-chlorothiophen-2-yl)-2-{[5-(4-hydroxyphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl}ethanone |
Depiction based on curated SMILES
S
OH
Cl
S
O
O
N
N
|
Mycobacterium |
ESX-1 (ESAT-6 secretion system-1) |
Preclinical (in vitro) |
Gries R, et al. 2024. Cell Chem Biol |
|
1-(azepan-1-yl)-3-[[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]propan-1-one |
Depiction based on curated SMILES
S
N
O
CH
3
O
N
N
|
Mycobacterium |
ESX-1 (ESAT-6 secretion system-1) |
Preclinical (in vitro) |
Gries R, et al. 2024. Cell Chem Biol |
|
2-(1-methylhydrazinyl)-4,6-di(piperidin-1-yl)-1,3,5-triazine |
Depiction based on curated SMILES
H
2
N
N
CH
3
N
N
N
N
N
|
Mycobacterium |
Motility |
Preclinical (in vitro) |
Ouertatani-Sakouhi H, et al. 2017. PLoS One |
|
1-[[5-tert-butyl-2-[(2,4-dichlorophenyl)methyl]pyrazole-3-carbonyl]amino]-3-phenylthiourea |
Depiction based on curated SMILES
HN
Cl
Cl
CH
3
S
NH
N
H
O
N
N
H
3
C
H
3
C
|
Mycobacterium |
Motility |
Preclinical (in vitro) |
Ouertatani-Sakouhi H, et al. 2017. PLoS One |
|
| | |